A Mitochondrial Dysfunction and Oxidative Stress Pathway-Based Prognostic Signature for Clear Cell Renal Cell Carcinoma

Figure 4

Prognostic value of MTG-based signature based on TCGA, E-MTAB-1980, and GSE29609 cohorts. (a) Kaplan-Meier survival curve analysis for overall survival grouped by the median risk score in the TCGA cohort; (b) time-dependent ROC curves measuring the predictive value of the risk score in the TCGA cohort; (c) distribution of the risk score, overall survival, and survival status of the prognostic signature in the TCGA cohort; (d) Kaplan-Meier survival curve analysis for overall survival grouped by the median risk score in the E-MTAB-1980 cohort; (e) time-dependent ROC curves measuring the predictive value of the risk score in the E-MTAB-1980 cohort; (f) Kaplan-Meier survival curve analysis for overall survival grouped by the median risk score in the GSE29609 cohort; (g) time-dependent ROC curves measuring the predictive value of the risk score in the GSE29609 cohort. (The statistical method was a log-rank test for a single factor, with only one test and the reported value was the value).

(a)

(b)

(c)

(d)

(e)

(f)

(g)